Charles Schwab Investment Management Inc Vigil Neuroscience, Inc. Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 20,643 shares of VIGL stock, worth $166,176. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,643Holding current value
$166,176% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding VIGL
# of Institutions
78Shares Held
37.9MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.84MShares$47 Million10.21% of portfolio
-
Beryl Capital Management LLC Redondo Beach, CA4.61MShares$37.1 Million5.55% of portfolio
-
Northpond Ventures, LLC4.21MShares$33.9 Million51.65% of portfolio
-
Glazer Capital, LLC New York, NY3.01MShares$24.2 Million0.86% of portfolio
-
Oddo Bhf Asset Management Sas Paris, I02.3MShares$18.5 Million0.72% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $228M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...